Alpha Amylase Market

Increasing Awareness about Health Benefits of Alpha Amylase in Animal Feed to Fuel Market Growth

Alpha Amylase Market by Form (Powder & Granules & Liquid), The market is bifurcated into powder, granules and liquid.

Industry: Food and Beverages

Published Date: March-2023

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 300

Report Price

$ 4900*

Buy Now
Request Report Sample

Report ID: PMRREP12172

Alpha Amylase Market Outlook (2023 to 2033)

The global market for Alpha Amylase accounted at US$ 1,840.8 Million for year 2023 and is anticipated to grow at value CAGR of 5.9% during the forecast period. The market value of Alpha Amylase is estimated to reach US$ 2,692.5 Million by end of 2033.

Alpha Amylase Market Size (2023E)

US$ 1,840.8 Million

Projected Sales of Alpha Amylase (2033F)

US$ 2,692.5 Million

Value CAGR (2023 to 2033)

5.9%

Value Share of Top 4 Countries (2022E)

41.7%

Alpha Amylase Consumption Analysis (2018 to 2022) Vs. Market Estimations (2023 to 2033)

During historical period of assessment (2018 to 2022), the market expanded at rate of 5.1% value CAGR, and earned a revenue of US$ 1,357.2 Million in 2018 and reached the value of US$ 1,722.3 Million by 2022. Furthermore, by source, the bacteria segment registered the highest market value share of above 45.00% in 2018.

The alpha-amylase market is profited from the higher utilization rate of alpha-amylase enzyme in multiple industries. The alpha-amylase is one of the mostly used enzymes in the food and beverage industry in bakery, brewing, sugar processing and other applications. Along with that, it is also applicable to the pharmaceutical, laboratory research, animal feed, and other different applications. Moreover, alpha-amylase is also a health beneficial ingredients for food and feed industry as it is associate with the enhancing the digestive system and improving the immune functions which is one of the advantageous factor for the global alpha-amylase market.

In the forecast period, the Alpha Amylase market is predicted to register the value of US$ 2,692.5 Million by end of 2033 and will grow at value CAGR of 5.9% owing to growing preference for natural ingredients across the end use industries.

What are the Key Trends in the Market for Alpha Amylase?

Rising Consumer Awareness Regarding Health Beneficial Products

Consumer awareness regarding health and wellness is increasing, which in turn is impacting their food consumption patterns. Increasing prevalence of various diseases is pushing customers towards health-consciousness and influencing them to opt for products with better health and nutrition value.

Food enzymes like alpha amylase are known to possess different health benefits like improved digestion and supporting immune system. Alpha amylase acts as catalysts, but in nature it is a natural protein, which provides numerous health benefits to the human body. Hence, the health and wellness trend among customers will prove to be beneficial for the growth of the alpha amylase market.

“Bio-preservation Trend Fuelling Alpha Amylase Demand in Food Industry”

Bio-preservation is a process of preserving food and extending its shelf-life by using antimicrobials or metabolic products. The demand for bio-preservation is increasing due to consumer demand for necessary safety standards in food products with increased shelf life.

With keeping the food products appealing and fresh for a longer time, producers of dairy, beverage, and fresh baking are focusing on finding natural ways to keep their portfolios fresh for longer time. As artificial preservatives today fail to meet the expectations of the modern consumers, alpha amylase plays an essential part of the bio-preservation process. Alpha amylase is capable of preserving food and providing safety standards to different food products.

  • According to the Food & Health Survey 2017, more than 70% of consumers check expiry dates of the products in supermarkets. This shows that, while consumers value clean label, natural products, shelf-life is also a key driver of purchasing behavior.

“Increasing Demand of Alpha Amylase in Pharmaceutical Industry to Bolster Sales”

The growing prevalence of diseases has enabled researcher in the pharmaceutical industry to innovate and develop holistic solutions for customers that supports consumer health. Alpha amylase has various health beneficial properties and hence is increasingly used in the pharmaceutical industry. Alpha-amylase is also becoming the prime ingredient for the pharmaceutical industry as it comprises the medicinal properties including the supports the immune system, management of inflammatory conditions, normalizes blood sugar, and others.

Alpha amylase has been scientifically proven that helps supporting digestion, providing more energy, supporting immune system, managing inflammatory conditions, and normalizing blood sugar. With numerous health benefits, it is majorly harnessed in medicines for supporting the immune system and for treating digestive disorders. The sedentary lifestyle along with unhealthy eating habits has amplified digestive disorders among consumers, thus, increasing the demand of alpha amylase in the pharmaceutical industry.

“High Cost of Alpha Amylase to Hamper Sales”

Alpha amylase is one of the most expensive enzymes. Alpha amylase is majorly used in different food industries such as bakery, dairy, beverages, starch processing, and others. The production needs to have a more specific environment, which needs heavy investment. For example, small increase and decrease in temperature can affect the properties of alpha amylase drastically. Therefore, enzymes are more expensive to utilize.

New and emerging applications of the alpha amylase have opened new vistas in field of their production methods immensely but being a part of the tedious production process makes alpha amylase expensive on the price scale. Thus, pushing potential customers away.

Country-wise insights

Which region is dominating the global Alpha Amylase market?

Europe dominates the global alpha-amylase market with the highest volume share of 28.0% in 2023. This is attributable to the higher number of end-user of alpha-amylase and vastly advance biotechnology industry in the region.

What is demand outlook for Alpha Amylase in South Asia?

The South Asia Alpha-Amylase market is estimated to be valued at US$ 185.1 Million by 2023 end, and is expected to reach US$ 415.9 Million by 2033 end, registering a CAGR of 8.4% over the forecast period.

Category-wise insights

What is bakery outlook for Alpha Amylase in the food and beverage industry?

Bakery, a sub-segment of food and beverage is projected to exhibit higher value CAGR of 7.3% in the global alpha-amylase market. The major contributing factor is its properties which enhances the shelf life of bakery products along with also improve the baking volume when used during manufacturing of bakery products. Moreover, the market demand of alpha amylase in confectionary industry is expected to reach US$ 232.8 Million by end 2033. In addition, consumption for bio-preservation is increasingly growing due to consumer demand for safety norms and standards in food products with extended shelf life.

What is the value share held by powder from alpha-amylase in the global market?

On the basis of form segment, the market is bifurcated into powder, granules and liquid. Owing to the easy availability and higher production volume, powder form of alpha-amylase is witnessing the prominent market value share of 78.3% in the global alpha-amylase market. Moreover, there is increasing the demand for liquid alpha-amylase attributing to the versatile application.

Competitive Dashboard

The major players in the global alpha-amylase market are adopting the strategy such as product diversification and higher spending on research and development. The key players including Novozymes, Lee BioSolution, and AB Enzymes are increasing their focus on expanding the geographical presence through strategic partnership as well as acquisition and offering the custom manufacturing services to customers. The manufacturers are also strategizing towards offering the high quality alpha-enzymes and new product development strategy to stay ahead in competition.

  • Aumgene Biosciences offers different enzymes, probiotics, and agri biotech products and also offers the contract services related to the fermentation and research to the various biotechnology companies. This displays the company’s capabilities regarding innovation and manufacturing of different biotechnology products.
  • Jiangsu Boli Bioproducts Co., Ltd. is also strongly focused towards the long-term customer partnership to meet the customer needs. The company is also continuously engaged in helping customers reduce production costs, increase yields, and minimize environmental impact.
  • Ottokemi is increasing its focus on custom manufacturing of chemical products as the company is equipped with in house manufacturing capabilities. The manufacturing facility allows to produce a wide range of products from gram to 100’s kg quantity.
  • Lee Biosolutions, Inc acquired Creative Laboratory Products and gained production rights of the complete products line of Creative Laboratory Products.The acquisition enabled the company to build upon extensive portfolio of enzymes, biochemical, and proteins for the life science and diagnostic manufacturing markets.
  • Karyotica Biologicals Pvt. Ltd. constantly with the help of research, identifies high enzyme yielding conditions to provide economical enzyme and enzyme products to the client. The company has technologies such as solid-state fermentation, submerged fermentation, strain development, and structure guided protein engineering technology for producing enzymes.

Alpha Amylase Industry Report Scope

Attribute

Details

Forecast period

2023 to 2033

Historical data available for

2018 to 2022

Market analysis

USD million for value

Key regions covered

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Key countries covered

  • United States
  • Canada
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • GCC countries
  • Turkey
  • Northern Africa
  • South Africa

Key market segments covered

  • Form
  • Application
  • Source

Key companies profiled

  • Novozymes
  • Aumgene Biosciences
  • Lee BioSolutions
  • AB Enzymes
  • Infinita Biotech Private Limited
  • Jiangsu Boli Bioproducts Co., Ltd.
  • Actiza Pharmaceutical Private Limited
  • Brisk Bioscience.
  • Sisco Research Laboratories Pvt Ltd
  • Karyotica Biologicals
  • Biolaxi Corporation
  • Creative Enzymes
  • Rejoice Life Ingredients
  • Enzyme Bioscience Pvt. Ltd.
  • Sunson Industry Group Co., Ltd.

Report coverage

  • Market forecast
  • Company share analysis
  • Competition intelligence
  • DROT analysis
  • Market dynamics and challenges
  • Strategic growth initiatives

Customization & pricing

Available upon request

Alpha Amylase Industry Research by Category

By Form:

  • Powder & Granules
  • Liquid

By Application:

  • Food & Beverage Industry
    • Confectionery
    • Bakery
    • Brewing
    • Other Processed Food
  • Pharmaceuticals
  • Animal Feed
  • Research
  • Detergent
  • Others

By Source:

  • Bacteria
  • Fungi
  • Plants & Animals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Novozymes
  • Aumgene Biosciences
  • Lee BioSolutions
  • AB Enzymes
  • Infinita Biotech Private Limited
  • Jiangsu Boli Bioproducts Co., Ltd.
  • Actiza Pharmaceutical Private Limited
  • Brisk Bioscience
  • Sisco Research Laboratories Pvt Ltd
  • Ottokemi
  • Sinobios
  • Karyotica Biologicals
  • Biolaxi Corporation
  • Creative Enzymes
  • Rejoice Life Ingredients
  • Enzyme Bioscience Pvt. Ltd.
  • Sunson Industry Group Co., Ltd.

Frequently Asked Questions

The global market for Alpha Amylase has a value of US$ 1,840.8 Mn in 2023.

The global market for Alpha Amylase has a value CAGR of 5.1% from 2018-2022.

The global market for Alpha Amylase has a value of US$ 2,692.5 Mn  in 2033.

The global market for Alpha Amylase has a value CAGR of 5.9% from 2023-2033.

Companies such  Novozymes, Lee BioSolution, AB Enzymes, Infinita Biotech, Brisk Bioscience, Jiangsu Boli , Sinobios, Creative Enzymes and more are the prominent players dominating the market.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate